Intravenous injection of cyclophilin A realizes the transient and reversible opening of barrier of neural vasculature through basigin in endothelial cells
Authors:
Open Access
- 29 September 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Abstract
Neural vasculature forms the blood–brain barrier against the delivery of systemically administered therapeutic drugs into parenchyma of neural tissues. Therefore, procedures to open the blood–brain barrier with minimal damage to tissues would lead to the great progress in therapeutic strategy for intractable neural diseases. In this study, through analyses with mouse in vitro brain microvascular endothelial cells and in vivo neural vasculature, we demonstrate that the administration of cyclophilin A (CypA), a ligand of basigin which is expressed in barrier-forming endothelial cells, realizes the artificial opening of blood–brain barrier. Monolayers of endothelial cells lost their barrier properties through the disappearance of claudin-5, an integral tight junction molecule, from cell membranes in a transient and reversible manner. Furthermore, the intravenous injection of a single dose of CypA into mice resulted in the opening of blood–brain barrier for a certain period which enabled the enhanced delivery of systemically administered doxorubicin into the parenchyma of neural tissues. These findings that the pre-injection of a single dose of CypA realizes an artificial, transient as well as reversible opening of blood–brain barrier are considered to be a great step toward the establishment of therapeutic protocols to overcome the intractability of neural diseases.Keywords
Funding Information
- Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18K07044)
This publication has 30 references indexed in Scilit:
- Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulationFluids and Barriers of the CNS, 2012
- Cyclophilin A (CyPA) Induces Chemotaxis Independent of Its Peptidylprolyl Cis-Trans Isomerase ActivityJournal of Biological Chemistry, 2011
- The many faces of EMMPRIN—Roles in neuroinflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injuryJournal of Neurosurgery, 2011
- Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeuticsClinical and Experimental Immunology, 2010
- Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer CellsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Hypoxia Disrupts the Barrier Function of Neural Blood Vessels through Changes in the Expression of Claudin-5 in Endothelial CellsThe American Journal of Pathology, 2007
- Dealing with the family: CD147 interactions with cyclophilinsImmunology, 2006
- Size-selective loosening of the blood-brain barrier in claudin-5–deficient miceJournal of Cell Biology, 2003
- Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147Journal of Biological Chemistry, 2002